FDA Adverse Event Injury Summary report: N

DERMAGRAFT

MDR report key: 215596 · Received March 24, 1999

Report

Report Number
2028403-1999-00001
Event Type
Injury
Date Received
March 24, 1999
Date of Event
February 19, 1999
Report Date
March 24, 1999
Manufacturer
ADVANCED TISSUE SCIENCES, INC.
Product Code
MGR
Removal / Correction Number
NA
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
UK
Reporter Occupation
PHYSICIAN

Narratives

Description of Event or Problem · 1

THIS 62 YEAR OLD FEMALE WAS ENROLLED IN A UNITED KINGDOM CLINICAL STUDY (NBT DCT 98/01) WHICH WAS DESIGNED TO STUDY VARIOUS TYPES OF SKIN ULCERS. THIS PT HAD AN ULCER ON THE RIGHT LEG OF A RHEUMATOID/VASCULITIC ETIOLOGY, AND THE PT WAS TAKING STEROIDS AND OTHER ANTI-INFLAMMATORY MEDICATION. SHE REC'D AN APPLICATION OF DERMAGRAFT ON 2/19/99 AND TWO HOURS LATER WAS NOTED TO HAVE CELLULITIS IN THE RIGHT LEG. ON THE CASE REPORT FROM THE PHYSICIAN DESCRIBED THE EVENT AS MILD, BUT STILL HOSPITALIZED THE PT ON 2/20/99 AND ADMINISTERED INTRAVENOUS ANTIBIOTICS. AS OF THE DATE OF THIS REPORT THE PT IS IMPROVED AND REMAINS ON ANTIBIOTICS IN THE HOSP. REGARDING THE RELATIONSHIP OF THE ADVERSE EVENT TO DERMAGRAFT, GIVEN A CHOICE BETWEEN "HIGHLY PROBABLE", "PROBABLE", "POSSIBLE", "REMOTE" AND "NONE", THE PHYSICIAN CHECKED "REMOTE".

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 DERMAGRAFT Implant HUMAN FIBROBLAST-DERIVED SKIN SUBSTITUTE MGR ADVANCED TISSUE SCIENCES, INC. ZT5000 104990

Patients

Seq Age Sex Outcome Treatment
1 62 YR Hospitalization SINCE 1996,| SINCE 1989,| SINCE 1994.| 1. AZATHIOPRINE (ANTI-INFLAMMATORY) 150 MG ORALLY| 1998 AND| 2. PREDNISOLONC (STEROID) 10MG ORALLY SINCE 1994,| ORALLY SINCE 1979.| 3. DIDRINAC (BONE DENSITY) 1.25G ORALLY SINCE 1996| 4. FERROUS SULPHATE (IRON SUPPLEMENT) 200MG ORALLY| 7. VITAMIN B (VITAMIN SUPPLEMENT) DOSE NOT KNOWN| 5. ALPHA CAPS (VITAMIN D SUPPLEMENT) 1 MG ORALLY| 6. TYLEX (ANALGESIC) DOSE NOT KNOWN, ORALLY SINCE